Law Martin, Wang Pei-Chun, Zhou Zhong-Yan, Wang Yu
Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong, Hong Kong SAR, China.
Pharmaceuticals (Basel). 2024 Nov 7;17(11):1495. doi: 10.3390/ph17111495.
Silent information regulator sirtuin 1 (SIRT1) is an NAD+-dependent deacetylase with potent anti-arterial aging activities. Its protective function in aging-related diseases has been extensively studied. In the microcirculation, SIRT1 plays a crucial role in preventing microcirculatory endothelial senescence by suppressing inflammation and oxidative stress while promoting mitochondrial function and optimizing autophagy. It suppresses hypoxia-inducible factor-1α (HIF-1α)-mediated pathological angiogenesis while promoting healthy, physiological capillarization. As a result, SIRT1 protects against microvascular dysfunction, such as diabetic microangiopathy, while enhancing exercise-induced skeletal muscle capillarization and energy metabolism. In the brain, SIRT1 upregulates tight junction proteins and strengthens their interactions, thus maintaining the integrity of the blood-brain barrier. The present review summarizes recent findings on the regulation of microvascular function by SIRT1, the underlying mechanisms, and various approaches to modulate SIRT1 activity in microcirculation. The importance of SIRT1 as a molecular target in aging-related diseases, such as diabetic retinopathy and stroke, is underscored, along with the need for more clinical evidence to support SIRT1 modulation in the microcirculation.
沉默信息调节因子sirtuin 1(SIRT1)是一种依赖烟酰胺腺嘌呤二核苷酸(NAD+)的去乙酰化酶,具有强大的抗动脉衰老活性。其在衰老相关疾病中的保护作用已得到广泛研究。在微循环中,SIRT1通过抑制炎症和氧化应激、促进线粒体功能以及优化自噬,在预防微循环内皮细胞衰老方面发挥关键作用。它抑制缺氧诱导因子-1α(HIF-1α)介导的病理性血管生成,同时促进健康的生理性毛细血管化。因此,SIRT1可预防微血管功能障碍,如糖尿病微血管病变,同时增强运动诱导的骨骼肌毛细血管化和能量代谢。在大脑中,SIRT1上调紧密连接蛋白并加强它们之间的相互作用,从而维持血脑屏障的完整性。本综述总结了关于SIRT1对微血管功能的调节、潜在机制以及在微循环中调节SIRT1活性的各种方法的最新研究结果。强调了SIRT1作为糖尿病视网膜病变和中风等衰老相关疾病分子靶点的重要性,同时也指出需要更多临床证据来支持在微循环中调节SIRT1。